Hand-Held Medical Robotics for Therapeutic Applications
Company Overview:
Houston Medical Robotics, Inc. (“HMR”) is developing & commercializing revolutionary image guided hand-held medical robotics for use in various therapeutic applications. Our devices provide safer, cheaper, and more effective procedural alternatives, thereby increasing caregiver efficiency, hospital/clinic revenue, and overall patient satisfaction.
Market Problem/Opportunity:
Over 5 million central venous catheters (“CVC”) are placed each year, representing a $750 million market, with a 2-26% complication rate due to procedural error costing the healthcare system billions of dollars. Image guided access has proven to reduce complications; however, the technique is cumbersome and not often utilized.
Solution:
HMR employees, in conjunction with our scientific advisors at Texas Heart Institute, Baylor College of Medicine, Rice University, and other institutions, have designed the EuclidTM vessel access system, a robust hand-held image guided medical robotic system for accessing the vasculature and other anatomical locations, including, but not limited to use in placement of CVC.
Business Model:
HMR has embarked on a three tier regulatory strategy, whereby the various aspects of the productized solution have been decoupled to minimize the potential regulatory clearance hurdles. HMR has received FDA 510(k) clearance for the EuclidTM Tier 1 Mini Access System. HMR is ramping up inventory for a US market launch and is seeking a strategic buyer or partner for world-wide sales, marketing, and distribution.
Competitive Advantages:
The EuclidTM provides faster, safer, cheaper, and more effective vascular access eliminating procedural complications, enabling less skilled operators to perform the requisite procedure, and allowing for rapid life saving intervention.